Seizures clinical trials in Florida
17 studies for Seizures are looking for participants at sites in Florida.
Cities in Florida
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Panhandle Research and Medical Clinic, LLC, Gulf Breeze
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07563881Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
- Mayo Clinic, Jacksonville
RecruitingEarly phase 1Mentions payment for participants
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07012148Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- University of Florida, Gainesville
Recruiting
Up to age 50 · All sexes · Updated Sep 17, 2026 · NCT02216500A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Pediatric Neurology and Epilepsy Specialists, Winter Park
RecruitingPhase 3
Ages 2 and older · All sexes · Updated Sep 15, 2026 · NCT04462770An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- University of Miami Miller School of Medicine, Miami
- AdventHealth Innovation Tower, Orlando
RecruitingPhase 3
Ages 2 to 55 · All sexes · Updated Sep 15, 2026 · NCT05066217Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- K2 Medical Research, Maitland
- Serenity Research Center, LLC, Miami
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT07594119A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
- Nova Clinical Research, LLC, Bradenton
- University of Florida (Jacksonville), Jacksonville
- University of Miami, Miami
- and 3 more
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Aug 24, 2026 · NCT06132893A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- University of South Florida, Tampa
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Aug 11, 2026 · NCT07233239Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- University of Miami, Miami
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jun 9, 2026 · NCT05135091RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Medsol Clinical Research Center, Port Charlotte
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jun 1, 2026 · NCT06798896AI-Based Mobile Intervention on Medication Non-Adherence and Transition
- Orlando Health Arnold Palmer Hospital, Orlando
- Orlando Health Orlando Regional Medical Center, Orlando
Recruiting
Ages 14 to 24 · All sexes · Updated May 29, 2026 · NCT07445074A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Panhandle Research and Medical Clinic, Gulf Breeze
- Mayo Clinic Florida, Jacksonville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT05716100Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
- Green Leaf Clinical Trials, LLC, Jacksonville
- Visionary Investigators Network, Miami
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Apr 21, 2026 · NCT05518578Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- Miami VA Healthcare System, Miami, FL, Miami
RecruitingPhase 4Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 20, 2026 · NCT04419272SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
- Medsol Clinical Research Center, Port Charlotte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 10, 2025 · NCT07141329Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Pediatric Epilepsy and Neurology Specialists, Tampa
RecruitingPhase 3
Ages 4 to 55 · All sexes · Updated Jul 24, 2025 · NCT05219617An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- Praxis Research Site, Miami Lakes
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Apr 3, 2025 · NCT06908356From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.